Mass Spectrometry Assay for Congenital Adrenal Hyperplasia
Quest Diagnostics Investments LLC
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 10 of these applications claim priority to application 61/140,824, filed Dec 24, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,415,616 | Mass Spectrometry Assay for Congenital Adrenal Hyperplasia In force · High confidence UsedRemaining | Quest Diagnostics Investments Incorporated | In force | High confidence | ||
| US 8,674,291 | Mass Spectrometry Assay for Congenital Adrenal Hyperplasia In force · High confidence | Quest Diagnostics Investments Incorporated | In force | High confidence | ||
| US 9,057,732 | Mass Spectrometry Assay for Congenital Adrenal Hyperplasia In force · High confidence | Quest Diagnostics Investments Inc. | In force | High confidence | ||
| US 9,541,562 | Mass Spectrometry Assay for Congenital Adrenal Hyperplasia In force · High confidence | Quest Diagnostics Investments Incorporated | In force | High confidence | ||
| US 9,921,231 | Mass Spectrometry Assay for Congenital Adrenal Hyperplasia In force · High confidence | Quest Diagnostics Investments Incorporated | In force | High confidence | ||
| US 10,429,396 | Mass Spectrometry Assay for Congenital Adrenal Hyperplasia In force · High confidence | Quest Diagnostics Investments Incorporated | In force | High confidence | ||
| US 10,697,980 | Mass Spectrometry Assay for Congenital Adrenal Hyperplasia In force · High confidence | Quest Diagnostics Investments Incorporated | In force | High confidence | ||
| US 10,948,501 | Mass Spectrometry Assay for Congenital Adrenal Hyperplasia In force · High confidence | Quest Diagnostics Investments Incorporated | In force | High confidence | ||
| US 12,196,765 | Mass Spectrometry Assay for Congenital Adrenal Hyperplasia In force · High confidence | Quest Diagnostics Investments Incorporated | In force | High confidence | ||
| US 8,153,962 | Mass Spectrometry Assay for Congenital Adrenal Hyperplasia In force · High confidence | Quest Diagnostics Investments LLC | In force | High confidence | ||
| 2 more records in this group · Pro | ||||||
10 of 12 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 12.
10 of these are in force and held by Quest Diagnostics Investments LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.